If you have lungs, you can get #lungcancer. ALK Positive ALK+ International Oncogene Cancer Research people.com/stephanie-will…

🛫💺Early morning flight heading to Barcelona. #ESMO24 Here we go!!!! ESMO - Eur. Oncology OncoAlert

Welcome to ESMO Congress 2024! One of the most awaited moments of the year! ESMO - Eur. Oncology #ESMO24

While I've been principally focused on GU abstracts at #ESMO24, it's worth noting that there are plenty of terrific #microbiome based presentations. On Saturday in the Valencia room, Bertrand Routy MD,PhD (who will be visiting City of Hope w Arielle Elkrief, MD FRCPC for a special symposium in

⭐️Manipulating the microbiome has huge potential in oncology and the field is just opening up. Terrific educational session & special symposium ESMO - Eur. Oncology #ESMO24 #ESMOambassadors Sumanta K. Pal, MD, FASCO 👇🏼

#ESMO24 starting today!! 🥳 ⬇️Join our 🌟amazing speakers🌟 at the #youngoncologist Vesalius talk and Mentorship session today! Matteo Lambertini, MD PhD Pawel Sobczuk Maria Kfoury Pablo Mando Deniz Can Guven Angelika Starzer Liz Connolly Rodrigo Sánchez-Bayona Elene Mariamidze

Ready for an amazing #ESMO2024 - if the data are as beautiful as this sunrise, it’s great news for patients!

Could we consider ceasing immunotherapy in patients who show a good response? This approach might optimize treatment regimens and minimize unnecessary therapy. ESMO - Eur. Oncology OncoAlert #ESMO2024

🔝 💥After the Versalius talk, stay behind to network with the Young Oncologists Committee members👀- we have 🍰🥐 Matteo Lambertini, MD PhD Pablo Mando Rodrigo Sánchez-Bayona Pawel Sobczuk Liz Connolly Angelika Starzer Myrto K. Moutafi Elene Mariamidze Emre Kocakavuk, MD, PhD Hongcheng Zhu 祝鸿程 Maria Kfoury Deniz Can Guven

To all young oncologists: looking forward to seeing you at the first #ESMOYOC session #VesaliusTalk led by Rille (YOC track chair for #ESMO24) & Pablo Mando with a super faculty Rebecca Dent FabriceAndre Lizzy Smyth ESMO - Eur. Oncology OncoAlert #ESMOAmbassadors

#ESMO24 in numbers, just #impressive -almost 33000 attendees -598 speakers -5030 abstracts submitted -2186 abstracts accepted -83 LBAs -3 plenary sessions -1+4 press conferences -151 proffered papers -207 mini orals -1828 posters ESMO - Eur. Oncology #ESMOAmbassadors

🌞 Today's the day! ⏰ The #ESMO24 Opening Ceremony kicks off at noon CEST with the presentation of the ESMO - Eur. Oncology Society Awards! 🫁 Stay tuned for lung-focused #ESMO2024 news here: buff.ly/3zsILC9 #lcsm #NSCLC #SCLC

We have started. Thank you Dr. Oosting for the shout out to Common Sense Oncology . #ESMO24 ESMO - Eur. Oncology

Great Sylvester Comprehensive Cancer Center Thoracic Site Disease Group retreat this week, bringing us together to work on multiD studies and improving care to our patients #researchmatters #teamwork #ClinicalTrials gilberto lopes

#ESMO24: Phase 2 CTBMS-986012 (anti-fucosyl-monosialoganglioside-1 [fuc-GM1]) with CE/NIVO as 1L in ES-SCLC: first interim readout NO differences in OS, primary endpoint no met. Great discussion by Stephen V Liu, MD highlighting the huge need of incorporating biomarkers.

Impressive benefit for Lenvatinib-Pembrolizumab in pts with thymic carcinoma and B3 thymoma. ORR 23.3% and mPFS 14.9m are unexpected in 2nd line or more. Lenvatinib dose matters in a subgroup analysis. Congratulations Jordi Remon #ESMO24

We are pleased to share this article out today in Cancer Discovery on the preclinical development and proof-of-concept clinical activity of NVL-655 ✅4th-generation, #ALK-selective TKI ✅CNS-penetrant ✅Broad coverage of ALK fusions and mutations, including lorlatinib-refractory compound

🚨#ESMO24 We’re ready for tomorrow’s big day, presenting key data on EGFR-mutant lung cancer. ⏱️08:30,Hall 2: OS Mariposa-2 update ⏱️ 10:15, Hall 5: Zipalertinib post-amivantamab in EGFR Ex20ins 🗓 Mark your calendars & make sure to attend #LCSM

A pleasure to host our visiting Hem-Onc Fellows Network Dr Ana Leticia from 🇧🇷National Institute of Cancer. #mentoringmatters gilberto lopes

Amazing achievement by Dr. Song, PGY2 at Jacobi Medical Center! He will be applying for a Hem/Onc fellowship next year, and any program would be fortunate to have him. Grateful to have played a small role in his journey.